These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3301213)

  • 1. Salicylate measurement: clinical usefulness and methodology.
    Kwong TC
    Crit Rev Clin Lab Sci; 1987; 25(2):137-59. PubMed ID: 3301213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Chyka PA; Erdman AR; Christianson G; Wax PM; Booze LL; Manoguerra AS; Caravati EM; Nelson LS; Olson KR; Cobaugh DJ; Scharman EJ; Woolf AD; Troutman WG; ;
    Clin Toxicol (Phila); 2007; 45(2):95-131. PubMed ID: 17364628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.
    Durnas C; Cusack BJ
    Drugs Aging; 1992; 2(1):20-34. PubMed ID: 1554971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal.
    Adelman HM; Wallach PM; Flannery MT
    J Rheumatol; 1991 Apr; 18(4):522-3. PubMed ID: 2066942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses].
    Vial A; Mathelier-Fusade P; Gaouar H; Leynadier F; Chosidow O; Aractingi S; Francès C
    Ann Dermatol Venereol; 2009 Jan; 136(1):15-20. PubMed ID: 19171224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays.
    Meany D; Schowinsky J; Clarke W
    Clin Biochem; 2008 Dec; 41(18):1486-8. PubMed ID: 18950612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aspirin and its application in canine veterinary medicine.
    Morton DJ; Knottenbelt DC
    J S Afr Vet Assoc; 1989 Dec; 60(4):191-4. PubMed ID: 2487727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fluorescence polarization immunoassay for salicylate to avoid positive/negative interference by bilirubin in the Trinder salicylate assay.
    Dasgupta A; Zaidi S; Johnson M; Chow L; Wells A
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):684-8. PubMed ID: 14629809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate levels in a stillborn infant born to a drug-addicted mother, with comments on pathology and analytical methodology.
    Aterman K; Holzbecher M; Ellenberger HA
    Clin Toxicol; 1980 May; 16(3):263-8. PubMed ID: 7398214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.
    Kapetanovic IM; Bauer KS; Tessier DM; Lindeblad MO; Zakharov AD; Lubet R; Lyubimov A
    Chem Biol Interact; 2009 May; 179(2-3):233-9. PubMed ID: 18992230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of aspirin.
    Levy G
    Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):867-72. PubMed ID: 724339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary?
    Wood DM; Dargan PI; Jones AL
    Emerg Med J; 2005 Jun; 22(6):401-3. PubMed ID: 15911944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of anti-inflammatory drugs.
    Kwong TC; Baum J
    Clin Lab Med; 1987 Sep; 7(3):687-97. PubMed ID: 3308303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is non-therapeutic aspirin use in children a problem in South Africa?
    Donald K; Hall S; Seaton C; Tanyanyiwa D
    S Afr Med J; 2011 Nov; 101(11):823-8. PubMed ID: 22272965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic monitoring of antidepressant drugs: guidelines updated.
    Orsulak PJ
    Ther Drug Monit; 1989 Sep; 11(5):497-507. PubMed ID: 2683251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.